NPI: 1497029664 · OXON HILL, MD 20745 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/05/2012
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/05/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,557 | $68K |
| 2019 | 17,149 | $110K |
| 2020 | 8,873 | $92K |
| 2021 | 4,200 | $78K |
| 2022 | 4,622 | $104K |
| 2023 | 3,684 | $147K |
| 2024 | 1,366 | $120K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 20,121 | 1,574 | $659K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,517 | 887 | $37K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,150 | 839 | $9K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 36 | 25 | $7K |
| J1756 | Injection, iron sucrose, 1 mg | 2,581 | 603 | $6K |
| 83970 | 752 | 641 | $1K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 27 | 12 | $785.07 |
| A4657 | Syringe, with or without needle, each | 1,409 | 1,094 | $420.81 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 54 | 43 | $1.86 |
| 85041 | 802 | 673 | $1.01 | |
| 82728 | 414 | 365 | $0.90 | |
| 85048 | 761 | 635 | $0.86 | |
| 83550 | 414 | 363 | $0.58 | |
| 83540 | 413 | 362 | $0.43 |